CLASS II ONGOING Device recall · Reported 13 Dec 2023 · FDA Enforcement Report

Monarch Platform recalled by Auris Health

Auris Health is recalling Monarch Platform, distributed in 34 states. The recall was initiated on 18 Oct 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSoftware version 2.2.4
Quantity recalled110 units In total

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0450-2024
FDA event ID
93320
Recalling firm
Auris Health, Redwood City, CA
Classification
Class II
Status
Ongoing
Recall initiated
18 Oct 2023
FDA classified
1 Dec 2023
Reported
13 Dec 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

18 Oct 2023Recall initiated by company
1 Dec 2023Classified by FDA+44 days
13 Dec 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Their is the potential that software issues may result in flipped image of the virtual Bronchoscope view.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Monarch Platform REF MON-000006 100-240V- 50/60Hz 1440w

Where it was distributed

US Distribution: AK, AL, AZ, CA, CO, CT, DC, DE, FL, GA, IL, IN, KY, MA, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NY, OH, OR, PA, SC, SD, TN, TX, WI & WV.

AlaskaAlabamaArizonaCaliforniaColoradoConnecticutDistrict of ColumbiaDelawareFloridaGeorgiaIllinoisIndianaKentuckyMassachusettsMichiganMinnesotaMissouriMississippiMontanaNorth Carolina

Questions about this recall

Is Monarch Platform recalled?

Yes. Auris Health recalled Monarch Platform on 18 Oct 2023. The recall is Class II and its status is Ongoing. Recall number Z-0450-2024.

Why was it recalled?

Their is the potential that software issues may result in flipped image of the virtual Bronchoscope view.

Which lots are affected?

Software version 2.2.4

Where was it sold?

US Distribution: AK, AL, AZ, CA, CO, CT, DC, DE, FL, GA, IL, IN, KY, MA, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NY, OH, OR, PA, SC, SD, TN, TX, WI & WV.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Auris Health

All 8

Other Other Medical Devices recalls

All 13,778